| # | Title | Journal | Year | Citations |
|---|
| 1 | Convolutional neural networks: an overview and application in radiology | Insights Into Imaging | 2018 | 2,388 |
| 2 | FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 | European Journal of Nuclear Medicine and Molecular Imaging | 2015 | 2,188 |
| 3 | Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients | European Journal of Nuclear Medicine and Molecular Imaging | 1993 | 1,430 |
| 4 | FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 | European Journal of Nuclear Medicine and Molecular Imaging | 2010 | 1,147 |
| 5 | A Review of Indocyanine Green Fluorescent Imaging in Surgery | International Journal of Biomedical Imaging | 2012 | 972 |
| 6 | Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use | European Journal of Nuclear Medicine and Molecular Imaging | 2000 | 913 |
| 7 | The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer | European Journal of Nuclear Medicine and Molecular Imaging | 2015 | 866 |
| 8 | Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer | European Journal of Nuclear Medicine and Molecular Imaging | 2014 | 817 |
| 9 | PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions | European Journal of Nuclear Medicine and Molecular Imaging | 2013 | 773 |
| 10 | Brain glucose metabolism in the early and specific diagnosis of Alzheimer?s disease | European Journal of Nuclear Medicine and Molecular Imaging | 2005 | 744 |
| 11 | Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? | Insights Into Imaging | 2012 | 738 |
| 12 | The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours | European Journal of Nuclear Medicine and Molecular Imaging | 2013 | 633 |
| 13 | Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2 | European Journal of Nuclear Medicine and Molecular Imaging | 2020 | 612 |
| 14 | Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis | Radiation Oncology | 2011 | 600 |
| 15 | Radiomics in medical imaging—“how-to” guide and critical reflection | Insights Into Imaging | 2020 | 599 |
| 16 | Guidelines for radioiodine therapy of differentiated thyroid cancer | European Journal of Nuclear Medicine and Molecular Imaging | 2008 | 593 |
| 17 | 68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0 | European Journal of Nuclear Medicine and Molecular Imaging | 2017 | 589 |
| 18 | Prognostic value of gated myocardial perfusion SPECT | Journal of Nuclear Cardiology | 2004 | 572 |
| 19 | Somatostatin receptor sst1–sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands | European Journal of Nuclear Medicine and Molecular Imaging | 2001 | 564 |
| 20 | Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study | European Journal of Nuclear Medicine and Molecular Imaging | 2003 | 510 |
| 21 | Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting | European Journal of Nuclear Medicine and Molecular Imaging | 2003 | 492 |
| 22 | Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients | European Journal of Nuclear Medicine and Molecular Imaging | 1996 | 481 |
| 23 | Efficient production of high specific activity 64Cu using a biomedical cyclotron | Nuclear Medicine and Biology | 1997 | 472 |
| 24 | Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC: preliminary data | European Journal of Nuclear Medicine and Molecular Imaging | 2001 | 470 |
| 25 | EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2 | European Journal of Nuclear Medicine and Molecular Imaging | 2009 | 469 |
| 26 | EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology | European Journal of Nuclear Medicine and Molecular Imaging | 2005 | 467 |
| 27 | Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours | European Journal of Nuclear Medicine and Molecular Imaging | 2007 | 467 |
| 28 | Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region | European Journal of Nuclear Medicine and Molecular Imaging | 2002 | 460 |
| 29 | ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers | Journal of Nuclear Cardiology | 2016 | 458 |
| 30 | Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: Comparison with ECG-gated Tc-99m sestamibi SPECT | Journal of Nuclear Cardiology | 2006 | 452 |
| 31 | Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose | European Journal of Nuclear Medicine and Molecular Imaging | 1996 | 450 |
| 32 | ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures | Journal of Nuclear Cardiology | 2016 | 450 |
| 33 | Quantitation of 211At in small volumes for evaluation of targeted radiotherapy in animal models | Nuclear Medicine and Biology | 1995 | 441 |
| 34 | [177Lu-DOTA0,Tyr3]octreotate: comparison with [111In-DTPA0]octreotide in patients | European Journal of Nuclear Medicine and Molecular Imaging | 2001 | 431 |
| 35 | Prospective comparison of 18 F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer | European Journal of Nuclear Medicine and Molecular Imaging | 1998 | 427 |
| 36 | Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients | European Journal of Nuclear Medicine and Molecular Imaging | 2017 | 425 |
| 37 | Myocardial perfusion scintigraphy: the evidence | European Journal of Nuclear Medicine and Molecular Imaging | 2004 | 424 |
| 38 | F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients | European Journal of Nuclear Medicine and Molecular Imaging | 2017 | 421 |
| 39 | Anatomy of SUV | Nuclear Medicine and Biology | 2000 | 419 |
| 40 | Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CT | European Journal of Nuclear Medicine and Molecular Imaging | 2009 | 419 |
| 41 | FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer’s disease | European Journal of Nuclear Medicine and Molecular Imaging | 2009 | 409 |
| 42 | Single photon-emission computed tomography | Journal of Nuclear Cardiology | 2010 | 404 |
| 43 | Early diagnosis and follow-up of aortitis with [18F]FDG PET and MRI | European Journal of Nuclear Medicine and Molecular Imaging | 2003 | 396 |
| 44 | Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis | European Journal of Nuclear Medicine and Molecular Imaging | 2013 | 395 |
| 45 | Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE | European Journal of Nuclear Medicine and Molecular Imaging | 2010 | 394 |
| 46 | PET attenuation coefficients from CT images: experimental evaluation of the transformation of CT into PET 511-keV attenuation coefficients | European Journal of Nuclear Medicine and Molecular Imaging | 2002 | 379 |
| 47 | Robust Vessel Segmentation in Fundus Images | International Journal of Biomedical Imaging | 2013 | 376 |
| 48 | Characterization of PET/CT images using texture analysis: the past, the present… any future? | European Journal of Nuclear Medicine and Molecular Imaging | 2017 | 376 |
| 49 | Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer | Radiation Oncology | 2012 | 375 |
| 50 | A gradient-based method for segmenting FDG-PET images: methodology and validation | European Journal of Nuclear Medicine and Molecular Imaging | 2007 | 373 |
| 51 | Quantification of myocardial blood flow with 82Rb dynamic PET imaging | European Journal of Nuclear Medicine and Molecular Imaging | 2007 | 373 |
| 52 | Standardized methods for the production of high specific-activity zirconium-89 | Nuclear Medicine and Biology | 2009 | 369 |
| 53 | Image Analysis for MRI Based Brain Tumor Detection and Feature Extraction Using Biologically Inspired BWT and SVM | International Journal of Biomedical Imaging | 2017 | 367 |
| 54 | Copper radionuclides and radiopharmaceuticals in nuclear medicine | Nuclear Medicine and Biology | 1996 | 361 |
| 55 | Graphical analysis of PET data applied to reversible and irreversible tracers | Nuclear Medicine and Biology | 2000 | 361 |
| 56 | Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers | European Journal of Nuclear Medicine and Molecular Imaging | 2008 | 359 |
| 57 | In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM | European Journal of Nuclear Medicine and Molecular Imaging | 2003 | 358 |
| 58 | Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors | European Journal of Nuclear Medicine and Molecular Imaging | 2015 | 357 |
| 59 | Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotate | European Journal of Nuclear Medicine and Molecular Imaging | 2003 | 356 |
| 60 | The detection rate of [11C]Choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer | European Journal of Nuclear Medicine and Molecular Imaging | 2008 | 355 |
| 61 | Nitroimidazoles and imaging hypoxia | European Journal of Nuclear Medicine and Molecular Imaging | 1995 | 354 |
| 62 | O -(2-[ 18 F]Fluoroethyl)- l -tyrosine and l -[methyl- 11 C]methionine uptake in brain tumours: initial results of a comparative study | European Journal of Nuclear Medicine and Molecular Imaging | 2000 | 353 |
| 63 | Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors | European Journal of Nuclear Medicine and Molecular Imaging | 2008 | 353 |
| 64 | Onset of left ventricular mechanical contraction as determined by phase analysis of ECG-gated myocardial perfusion SPECT imaging: Development of a diagnostic tool for assessment of cardiac mechanical dyssynchrony | Journal of Nuclear Cardiology | 2005 | 352 |
| 65 | Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study | European Journal of Nuclear Medicine and Molecular Imaging | 2011 | 349 |
| 66 | Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours | European Journal of Nuclear Medicine and Molecular Imaging | 1997 | 348 |
| 67 | Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0 | European Journal of Nuclear Medicine and Molecular Imaging | 2019 | 348 |
| 68 | Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer | European Journal of Nuclear Medicine and Molecular Imaging | 2020 | 348 |
| 69 | Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals? | European Journal of Nuclear Medicine and Molecular Imaging | 2007 | 347 |
| 70 | A review on the clinical uses of SPECT/CT | European Journal of Nuclear Medicine and Molecular Imaging | 2010 | 347 |
| 71 | Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association | Journal of Nuclear Cardiology | 2002 | 346 |
| 72 | Radioimmunotherapy with alpha-emitting nuclides | European Journal of Nuclear Medicine and Molecular Imaging | 1998 | 343 |
| 73 | The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials | European Journal of Nuclear Medicine and Molecular Imaging | 2008 | 343 |
| 74 | Serotonin-1A receptor imaging in recurrent depression: replication and literature review | Nuclear Medicine and Biology | 2007 | 341 |
| 75 | FDG-PET for clinical use | European Journal of Nuclear Medicine and Molecular Imaging | 2001 | 338 |
| 76 | PET imaging with 89Zr: From radiochemistry to the clinic | Nuclear Medicine and Biology | 2013 | 338 |
| 77 | Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer | European Journal of Nuclear Medicine and Molecular Imaging | 2011 | 337 |
| 78 | The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease | European Journal of Nuclear Medicine and Molecular Imaging | 2005 | 334 |
| 79 | FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC | European Journal of Nuclear Medicine and Molecular Imaging | 2018 | 332 |
| 80 | EANM guidelines for ventilation/perfusion scintigraphy | European Journal of Nuclear Medicine and Molecular Imaging | 2009 | 328 |
| 81 | Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis | European Journal of Nuclear Medicine and Molecular Imaging | 2011 | 323 |
| 82 | FDG Accumulation and Tumor Biology | Nuclear Medicine and Biology | 1998 | 320 |
| 83 | Radiation dosimetry and first therapy results with a 124I/131I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy | European Journal of Nuclear Medicine and Molecular Imaging | 2014 | 319 |
| 84 | Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA | European Journal of Nuclear Medicine and Molecular Imaging | 2017 | 319 |
| 85 | O-(2-[18F]fluoroethyl)-l-tyrosine: uptake mechanisms and clinical applications | Nuclear Medicine and Biology | 2006 | 317 |
| 86 | PET-guided delineation of radiation therapy treatment volumes: a survey of image segmentation techniques | European Journal of Nuclear Medicine and Molecular Imaging | 2010 | 316 |
| 87 | 213Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience | European Journal of Nuclear Medicine and Molecular Imaging | 2014 | 316 |
| 88 | Towards quantitative PET/MRI: a review of MR-based attenuation correction techniques | European Journal of Nuclear Medicine and Molecular Imaging | 2009 | 314 |
| 89 | Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: Results of the ADVANCE phase 3 multicenter international trial | Journal of Nuclear Cardiology | 2007 | 311 |
| 90 | Underestimation of extent of ischemia by gated SPECT myocardial perfusion imaging in patients with left main coronary artery disease | Journal of Nuclear Cardiology | 2007 | 310 |
| 91 | [18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients | European Journal of Nuclear Medicine and Molecular Imaging | 2006 | 304 |
| 92 | Comparison of bone scintigraphy and 68Ga-PSMA PET for skeletal staging in prostate cancer | European Journal of Nuclear Medicine and Molecular Imaging | 2016 | 302 |
| 93 | PET-CT image co-registration in the thorax: influence of respiration | European Journal of Nuclear Medicine and Molecular Imaging | 2002 | 301 |
| 94 | Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis | European Journal of Nuclear Medicine and Molecular Imaging | 2008 | 301 |
| 95 | The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies | Radiation Oncology | 2018 | 301 |
| 96 | Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma | European Journal of Nuclear Medicine and Molecular Imaging | 2010 | 298 |
| 97 | Yttrium-90 DOTATOC: first clinical results | European Journal of Nuclear Medicine and Molecular Imaging | 1999 | 295 |
| 98 | Current use and future potential of organometallic radiopharmaceuticals | European Journal of Nuclear Medicine and Molecular Imaging | 2002 | 295 |
| 99 | Consensus Recommendations for Gastric Emptying Scintigraphy: A Joint Report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine | Journal of Nuclear Medicine Technology | 2008 | 295 |
| 100 | Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology | European Journal of Nuclear Medicine and Molecular Imaging | 2010 | 295 |
